|Bid||84.00 x 900|
|Ask||85.40 x 2200|
|Day's Range||83.77 - 85.32|
|52 Week Range||77.04 - 98.52|
|Beta (5Y Monthly)||0.55|
|PE Ratio (TTM)||21.49|
|Forward Dividend & Yield||3.20 (3.84%)|
|Ex-Dividend Date||Mar 04, 2021|
|1y Target Est||104.80|
Subscribe to Yahoo Finance Plus to view Fair Value for NVSLearn more
Novartis stock jumped Tuesday after the company said it's considering selling or spinning off its underperforming generics business, Sandoz.
NVS earnings call for the period ending September 30, 2021.
Novartis (NVS) reports mixed results in the third quarter, as key brands maintain momentum but generics business remains weak.